AstraZeneca (AZN) logo

AstraZeneca (AZN) stock

Branded drugs , market cap $290B

$186.32
-1.62%

As of 11:01 AM ET, delayed 15+ min · Live for Pro members

Quality Score
10
Average
In its industry
#21of 90
Checks firing
4of 14
Trending down
From 52-week high
-12.4%
under its best in a year

AZN's Quality Score fell 3 points on Tue, Nov 10, to 10.

Follow AZN's trial news. Pro members can get an alert when AstraZeneca files news, and see its trials, share raises, and its CEO's filings.

Get an alert when AZN files news on its trialsSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextDec 31, 2026 · In 51 daysDurvalumab, Phase 3 ROSY-D, the sponsor's estimatePhase 3 main data due · ClinicalTrials.gov · Oct 26

Why AZN rose on Oct 22

Up 2% on Oct 22.

  • Our sources do not explain the move yet.
  • The S&P 500 fell 1.2% that day.

Sources: Price history, Oct 22, 2026

Key facts on AZN

Key facts on AZN
The companyProfit up 45% to $10.2B
Latest filing20-F, Feb 24 Filed its annual report (20-F) for the year to Dec 31, 2025
1 more reason behind AZN's 10, free with an account →1 more reason behind AZN's 10, for Pro members.

AZN in the news

Thu Nov 5AstraZeneca Pharma India names Atul Tandon CFO effective Nov 9 multibagg ai and 1 more · yesterday 7:53 AM ET AZN closed −1.1% that day.

Big story

Tue Sep 29: FDA

AstraZeneca seeks FDA approval of HUTCHMED lung cancer drug

AZN closed −1.2% that day.

Reported by arynews.tv · covered by 91 outlets

Get an alert on AZN's next big story →

Outlet counts from the GDELT Project. The move is what AZN did that session, not a claim about why.

What's next

Expected to report Thu Nov 12, before the open

After its last 2 reports it closed +3.0% on average, higher 2 of 2 times.

AZN catalysts

Coming up

3 more coming up and 43 past catalysts since 2018, with sizes and sources, for Pro members.

What's next for AZN

Next Phase 3 data on the registry

Dec 31In 51 daysDurvalumab, Phase 3 ROSY-D: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabPhase 3 main data due · ClinicalTrials.gov · Oct 26

What it means: the date the registry lists for the trial’s last main measurement, as the sponsor estimates it. Results usually follow weeks to months later.

A trial underway
DOMINICAPhase 3 · Active · 94 people · main data estimated Dec 23, 2026 · NCT05692180

355 more trials, 12 with data due this year, 88 drugs past Phase 1 and 305 filings, for Pro members.

Dilution on the horizon

  • Shelf registration (F-3ASR, filed Mar 19, 2024)

For Pro members: the amounts, and the share count against a year ago.

Insiders

An officer, Mani Sharma, bought 20 shares on Aug 8. 1 more insider trade this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why AZN scores 10

Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

  • +4Chart checks 4 of 14 firing right now, one point each
  • +2Long-term trend above a rising 200-⁠day average
  • Size adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Run-up, Growth, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on AZN and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 11:01 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How AZN ranks in Pharma

AZN is #21 of 90 by Quality Score.

How AZN ranks in Pharma
RankStockQuality Score
21AstraZeneca (AZN) logoAZNAstraZeneca10

More in Pharma

When does AZN report earnings, and what happens after?

Expected to report Thu Nov 12, before the open (in 2 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Close after the report, last 2

+3.2%+2.9%
Nov 6Feb 10
ReportedGapReaction5
days
Feb 10, 2026Before open+3.2%+2.9%+11.4%
Nov 6, 2025Before open+3.9%+3.2%+8.1%

AZN closed higher after 2 of its last 2 reports.

Everyone reporting earnings this week

AZN sales and profit by year

Sales and profit by year

Sales grew every year from 2018 to 2025, to $59B. It made a profit in each of the eight years.

AZN has 4 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on AZN, and all 14 on every stock.Get in free →

AZN RSI today: 65.4, above its 50-day and 200-day averages

Not scored

RSI 65.4, MACD above signal, above both averages. Not scored.

The deep dive on AZN

8 more findings on AZN, each with its source, for Pro members.

AZN share count over time

Offerings, shelves, and splits of AZN, from its filings
From its
filings
Filed
Registered shares for a later sale (F-3ASR)Mar 19, 2024

AZN insider trades

One insider sold $2.2M across 1 filing in the last 6 months. No open-⁠market buys on record. The newest:

SellMani Sharma$2.2MInsiderat $185.78 on May 20, filed May 22

AZN trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

BuyAlan Armstrong$1K to $15KSenatetraded Mar 31, disclosed Jul 21(112 days later)
All 2 trades on AZN disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

AZN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

About AstraZeneca

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

96,100 employeesastrazeneca.com

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on AZN and every other stock.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would move AZN's score: 4 things
  • 11 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayJul 21Alan Armstrong bought AZN$1K to $15K, disclosed Jul 21

Alerts are optional.

See AZN's 14 chart checks

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: AZN's Quality Score is 10 (Average), #21 of 90 in Pharma. Insiders sold $2.2M in the last 6 months (Form 4).

What does AZN's Quality Score say?

AZN scores 10 today, which Breakaway calls Average. It is #21 of 90 in Pharma by Quality Score, with 4 of 14 chart checks firing. Up 2% on Oct 22. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is AZN's Quality Score?

AZN scores 10 today, which Breakaway calls Average (6 to 10). That is #21 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AZN's 10.

Are insiders buying AZN?

One insider sold $2.2M across 1 filing in the last 6 months. No open-⁠market buys on record. The newest is Mani Sharma, Insider, who sold $2.2M on May 20.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,168 stocks ranked

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

What's next for AstraZeneca: from its SEC filings and ClinicalTrials.gov, the company's words, the registry's dates, and arithmetic, not a forecast. Companies often miss the dates they set.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.